Evidence of immune activation and inflammation has been found in the brain tissue of patients with Alzheimer's disease (AD). If inflammation contributes to the pathogenesis of AD, perhaps nonsteroidal anti-inflammatory drugs (NSAIDs) could slow the course of the …